NR565/ NR 565 Advanced Pharmacology
Care of the Fundamentals Midterm Exam.
100% Complete Questions and VERIFIED
Answers 2026/2027
1. In patients with infrequent flareups (less than three per year), NSAIDs are the first line agent for
relieving pain- ANS>>Gouty Arthritis Treatment Decision
2. Prescribe a glucocorticoid (prednisone) or make dietary changes- ANS>>Gouty Arthritis NSAID
Ineffectiveness
3. Considered for long term treatment if a person has three or more gouty attacks per year-
ANS>>Colchicine Long Term Treatment
4. Should not be taken with statins or CYP3A4 inhibitors- ANS>>Colchicine Contraindications
5. Nausea, vomiting, diarrhea, myelosuppression, myopathy, and rhabdomyolysis-
ANS>>Colchicine Adverse Effects
6. Can lead to severe cutaneous adverse reaction (SCAR) with symptoms like rash, fever,
eosinophilia, and liver and kidney function issues- ANS>>Allopurinol Long Term Effect
7. Should be co-administered with NSAIDs or colchicine- ANS>>Febuxostat Co- Administration
8. Erosion and irreversible joint damage, renal damage, and tophi formation- ANS>>Untreated
Gout Complications
9. Minimize risk of esophagitis by swallowing the pill whole with a full glass of water, then sitting up
for at least 30 min, and taking the med 30 min prior to other intake- ANS>>Alendronate Patient
Education
10. Interferes with calcium, magnesium, and iron absorption- ANS>>Ibandronate Dietary
Supplement Interference
11. Alendronate is the first line treatment- ANS>>Osteoporosis 1st Line Treatment
12. Safe to use in patients with renal dysfunction or who over produce uric acid- ANS>>Allopurinol
Safety in Renal Dysfunction
13. Includes CBC with WBC differential, s/s of infection, malignancies, pregnancy rule out, ALT,
AST, serum creatinine, comprehensive history and physical exam, and
, 14. assessment of immunocompetence and liver and renal status- ANS>>DMARDs Baseline
Diagnostics
15. Includes chest x-ray with emphasis on pulmonary and GI status- ANS>>Methotrexate Baseline
Data
16. Hydroxychloroquine- ANS>>DMARD Requiring Ophthalmologic and Cardiac Exam
17. Risk for venous thromboembolic events (DVT, PE, stroke)- ANS>>Raloxifene Black Box
Warning
18. Reinforcing properties of drugs, physical and physiological dependence, social factors, drug
availability, individual vulnerability, impulsivity, low tolerance for frustration, and specific
personality disorders- ANS>>Controlled Substance Addiction Predictors
19. Adjuvant analgesic for neuropathic pain, effective in diabetic neuropathy, seizures, central
neuropathy, postherpetic neuralgia, and fibromyalgia- ANS>>Pregabalin Chronic Pain
Treatment
20. Sedation, drowsiness, dizziness, ataxia, blurred vision, and difficulty thinking- ANS>>Pregabalin
Adverse Effects
21. Linked to COX-2 inhibitors and NSAIDs- ANS>>GI Bleeding Link
22. Start taking this medicine at the first sign of the attack for best results, stop taking this medicine
as soon as the pain is relieved or at the first sign of nausea, vomiting, stomach pain, or
diarrhea- ANS>>Colchicine Patient Education
23. Methotrexate, leflunomide, and biologics like anti-TNF agents, rituximab, and abatacept -
ANS>>RA High Risk Drugs in Pregnancy
24. NSAIDs, corticosteroids, and several DMARDs including sulfasalazine and hydroxychloroquine-
ANS>>RA Safe Drugs in Pregnancy
25. May increase the risk for myocardial infarction, stroke, and other thromboembolic events, as
well as dangerous gastrointestinal adverse effects such as bleeding, ulceration, and perforation-
ANS>>NSAID Black Box Warning
26. Interacts with mercaptopurine and azathioprine, warfarin, theophylline, and ampicillin-
ANS>>Allopurinol Drug Interactions
27. Takes 3 to 6 weeks for symptoms to improve, and 12 weeks or longer for full benefit-
ANS>>Methotrexate Therapeutic Response
28. Osteonecrosis of the jaw and hip fracture, as well as esophagitis- ANS>>Bisphosphonates
Adverse Effects
Care of the Fundamentals Midterm Exam.
100% Complete Questions and VERIFIED
Answers 2026/2027
1. In patients with infrequent flareups (less than three per year), NSAIDs are the first line agent for
relieving pain- ANS>>Gouty Arthritis Treatment Decision
2. Prescribe a glucocorticoid (prednisone) or make dietary changes- ANS>>Gouty Arthritis NSAID
Ineffectiveness
3. Considered for long term treatment if a person has three or more gouty attacks per year-
ANS>>Colchicine Long Term Treatment
4. Should not be taken with statins or CYP3A4 inhibitors- ANS>>Colchicine Contraindications
5. Nausea, vomiting, diarrhea, myelosuppression, myopathy, and rhabdomyolysis-
ANS>>Colchicine Adverse Effects
6. Can lead to severe cutaneous adverse reaction (SCAR) with symptoms like rash, fever,
eosinophilia, and liver and kidney function issues- ANS>>Allopurinol Long Term Effect
7. Should be co-administered with NSAIDs or colchicine- ANS>>Febuxostat Co- Administration
8. Erosion and irreversible joint damage, renal damage, and tophi formation- ANS>>Untreated
Gout Complications
9. Minimize risk of esophagitis by swallowing the pill whole with a full glass of water, then sitting up
for at least 30 min, and taking the med 30 min prior to other intake- ANS>>Alendronate Patient
Education
10. Interferes with calcium, magnesium, and iron absorption- ANS>>Ibandronate Dietary
Supplement Interference
11. Alendronate is the first line treatment- ANS>>Osteoporosis 1st Line Treatment
12. Safe to use in patients with renal dysfunction or who over produce uric acid- ANS>>Allopurinol
Safety in Renal Dysfunction
13. Includes CBC with WBC differential, s/s of infection, malignancies, pregnancy rule out, ALT,
AST, serum creatinine, comprehensive history and physical exam, and
, 14. assessment of immunocompetence and liver and renal status- ANS>>DMARDs Baseline
Diagnostics
15. Includes chest x-ray with emphasis on pulmonary and GI status- ANS>>Methotrexate Baseline
Data
16. Hydroxychloroquine- ANS>>DMARD Requiring Ophthalmologic and Cardiac Exam
17. Risk for venous thromboembolic events (DVT, PE, stroke)- ANS>>Raloxifene Black Box
Warning
18. Reinforcing properties of drugs, physical and physiological dependence, social factors, drug
availability, individual vulnerability, impulsivity, low tolerance for frustration, and specific
personality disorders- ANS>>Controlled Substance Addiction Predictors
19. Adjuvant analgesic for neuropathic pain, effective in diabetic neuropathy, seizures, central
neuropathy, postherpetic neuralgia, and fibromyalgia- ANS>>Pregabalin Chronic Pain
Treatment
20. Sedation, drowsiness, dizziness, ataxia, blurred vision, and difficulty thinking- ANS>>Pregabalin
Adverse Effects
21. Linked to COX-2 inhibitors and NSAIDs- ANS>>GI Bleeding Link
22. Start taking this medicine at the first sign of the attack for best results, stop taking this medicine
as soon as the pain is relieved or at the first sign of nausea, vomiting, stomach pain, or
diarrhea- ANS>>Colchicine Patient Education
23. Methotrexate, leflunomide, and biologics like anti-TNF agents, rituximab, and abatacept -
ANS>>RA High Risk Drugs in Pregnancy
24. NSAIDs, corticosteroids, and several DMARDs including sulfasalazine and hydroxychloroquine-
ANS>>RA Safe Drugs in Pregnancy
25. May increase the risk for myocardial infarction, stroke, and other thromboembolic events, as
well as dangerous gastrointestinal adverse effects such as bleeding, ulceration, and perforation-
ANS>>NSAID Black Box Warning
26. Interacts with mercaptopurine and azathioprine, warfarin, theophylline, and ampicillin-
ANS>>Allopurinol Drug Interactions
27. Takes 3 to 6 weeks for symptoms to improve, and 12 weeks or longer for full benefit-
ANS>>Methotrexate Therapeutic Response
28. Osteonecrosis of the jaw and hip fracture, as well as esophagitis- ANS>>Bisphosphonates
Adverse Effects
